138 related articles for article (PubMed ID: 2485273)
1. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
2. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
3. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
4. The significance of fibrinogen derivatives in plasma in human renal failure.
Lane DA; Ireland H; Knight I; Wolff S; Kyle P; Curtis JR
Br J Haematol; 1984 Feb; 56(2):251-60. PubMed ID: 6229269
[TBL] [Abstract][Full Text] [Related]
5. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
Marongiu F; Mameli G; Acca MR; Mulas G; Medda A; Tronci MB; Mamusa AM; Balestrieri A
Haemostasis; 1988; 18(2):126-8. PubMed ID: 2457543
[TBL] [Abstract][Full Text] [Related]
6. [Clinical tests on the diagnosis of thrombosis].
Yamanaka M
Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
[No Abstract] [Full Text] [Related]
7. Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.
Tomura S; Oono Y; Kuriyama R; Takeuchi J
Arch Intern Med; 1985 Jun; 145(6):1033-5. PubMed ID: 4004427
[TBL] [Abstract][Full Text] [Related]
8. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
9. Objective assessment of heparin requirements for hemodialysis in humans.
Ireland H; Lane DA; Curtis JR
J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation and fibrinopeptide formation in pulmonary hypertension.
Schulman LL; Grossman BA; Owen J
Chest; 1993 Dec; 104(6):1690-3. PubMed ID: 8252943
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
Kaplan KL; Nossel HL; Drillings M; Lesznik G
Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
[TBL] [Abstract][Full Text] [Related]
13. Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis.
Miura M; Tomino Y; Inoue W; Yagame M; Tamura S; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1986 Oct; 11(4):273-7. PubMed ID: 3617111
[TBL] [Abstract][Full Text] [Related]
14. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
Uchiba M; Okajima K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
[No Abstract] [Full Text] [Related]
15. [Plasma fibrinopeptide A, fibrinopeptide B beta 15-42 and 4 other coagulation factors levels in patients with diabetic retinopathy].
Yamamoto M; Denno S; Sunakawa M
Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1443-8. PubMed ID: 1476075
[TBL] [Abstract][Full Text] [Related]
16. Activation of coagulation and fibrinolytic systems following stroke.
Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers of hemostasis activation in nephrotic syndrome.
Sagripanti A; Cupisti A; Ferdeghini M; Pinori E; Barsotti G
Nephron; 1989; 51(1):25-8. PubMed ID: 2521695
[TBL] [Abstract][Full Text] [Related]
18. ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.
Papp AC; Hatzakis H; Bracey A; Wu KK
Thromb Haemost; 1989 Feb; 61(1):15-9. PubMed ID: 2526384
[TBL] [Abstract][Full Text] [Related]
19. [Serial changes in FPA and FPB beta 15-42 during surgery with cardiopulmonary bypass].
Gando S; Tedo I; Tsujinaga H; Kubota M
Masui; 1988 May; 37(5):541-5. PubMed ID: 3411777
[No Abstract] [Full Text] [Related]
20. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
